2
Feb
2018

Amazon Sizes Up Healthcare Beast, Vertex Raises the Bar in CF, Moderna Hauls in Another $500M

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.

 
 

You may also like

An IPO Trio, Veradermics’ Hair Loss Win, & Erasca’s Rough Week
Lilly Buys In Vivo CAR-T, Psychedelics in the Fast Lane, Nektar Surges on Hair Loss Drug
RevMed Nails RAS, Lilly Acquires CrossBridge, & IPOs Line Up
Gilead’s Deal Streak, Neurocrine Grows, & Stipple & Sidewinder Megarounds